Company profile
PharmaTher Holdings Ltd.
OTC: PHRRF · Healthcare · Biotechnology
Canadian filerHQ Toronto, ONReports USD
#1166 of 1,422 Healthcare companies by revenue
EA Score
——FH —DQ —GM —SS 26
v0.1 · 5/100 weight · pillars only
↑ balance-sheet leverage, disclosure history · ↓ Piotroski F, workforce scale
Methodology →Revenue TTM
$0
Rev growth YoY (TTM)
needs 8 qtrs
Net income (FY)
-$1.1M
Employees
5
as of 2026-08-24
Market cap
$4.0M
as of 2026-08-24
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$00 CAD2025
Net income-$1.1M-1.5M CAD2025
Operating income-$1.1M-1.5M CAD2025
Total assets$973.9k1.3M CAD2025
Liabilities$266.3k366.3k CAD2025
Equity$707.6k973.5k CAD2025
Revenue trend
FY2020 – FY2025 · USD
FY20
FY21
FY22
FY23
FY24
FY25
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is PharmaTher Holdings Ltd.’s revenue?
PharmaTher Holdings Ltd. booked $0 in FY2025 revenue — among the slowest-growing Healthcare companies we track, at a -Infinity% net margin.
Peers · Healthcare
WEED, Inc.19DMustang Bio, Inc.41DStimcell Energetics, Inc.20DQuest PharmaTech Inc.——nDatalyze Corp.47DElixxer Ltd.14DKey facts
CEOFabio Chianelli
SectorHealthcare
IndustryBiotechnology
HeadquartersToronto, ON
ExchangeOTC: PHRRF
Employees5
IPO date2021-01-08
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.